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Abstract
Background: Standardizing concentrations of intravenous infusions enables pre-preparation and is effective in
improving patient safety by avoiding large deviations from the prescribed concentration that can occur when
infusions are made individually in wards and theatres. The use of pre-prepared morphine standardized
concentration infusions for paediatric nurse/patient-controlled analgesia (N/PCA) has not been previously
investigated. We aimed to establish, implement and evaluate standardized concentrations of morphine in pre-
filled syringes (PFS) for use in paediatric N/PCA.
Methods: Concentrations of morphine in PFS for N/PCA were identified that accommodated dosage variation
across a 1–50 kg weight range. The use of infusions in PFS was implemented and evaluated using mixed
methods involved direct observation of healthcare professionals (HCPs), focus groups and failure mode and
effects analysis, a HCP survey and medication incident reports analysis.
Results: Standardized concentrations, 3 mg, 10 mg and 50 mg morphine in 50 mL sodium chloride 0.9%,
delivered prescribed continuous and bolus doses using programmable smart pumps with variable infusion
rates. During the implementation, 175 morphine pre-prepared infusions were administered to 157 children
(9.4 ± 5.1 years) in theatres and wards. Time taken to set up a N/PCA was 3.7 ± 1.7 min, a reduction of one
third compared with the previous system. The number of incidents associated with N/PCA infusions was
reduced by 41.2%, and preparation errors were eliminated. HCPs reported using morphine PFS was an easier
and safer system.
Conclusion: A system using pre-prepared standardized concentrations of morphine for paediatric N/PCA was
implemented successfully and sustainably.
Keywords: Standard infusion, Morphine, Ready-to-administer infusions, Children, Pre-filled syringe,
Implementation, Nurse/patient-controlled analgesia
Background
Individually prepared morphine intravenous infusions
have been associated with significant errors [1–3], lead-
ing to development of “ready-to-administer (RTA)”
products [3–6]. Pre-prepared syringes containing stan-
dardized concentrations of drugs are recognized as im-
portant in improving patient safety by reducing medica-
tion errors [3–7]. A UK study reported aseptically pre-
pared standardized dose-banded syringes, used with a
pre-programmed safety pump was likely to reduce dos-
ing errors in children [8].
Currently in European hospitals, morphine infusions are
prepared for each paediatric patient based on their weight,
using the “rule of six” formula [9]. This formula is de-
scribed as: 6 x patient’s weight (kg) equals the amount of
drug in milligrams that should be added to 100mL of so-
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lution. When administered at 1mL/h will give an infusion
rate of 1 microgram/kg/min (or 60 microgram/kg/h). This
is error prone, which may lead to significant over or under
dosing, resulting in adverse events, e.g. hypoventilation
[10] or inadequate analgesia [11, 12].
At the study hospital, a morphine prefilled syringe
(PFS) system is only used to deliver continuous infusions
to critically ill children in the paediatric intensive care
unit (PICU) [13]. This resulted in two systems within
PICU; standard concentrations for continuous infusions
and individually prepared infusions for nurse/patient--
controlled analgesia (N/PCA), which contributed to
medication errors [11, 12].
Pre-implementation studies involving direct observa-
tion of morphine infusion preparation, with morphine
concentration quantification [11] and focus groups to
assess the prescribing, preparing and administering of
morphine infusion for paediatric N/PCA [12], identi-
fied risks in the established process, including signifi-
cant deviations in the prepared infusions from the
prescribed dose. Participants suggested providing
standard concentration of morphine in a RTA form
would improve current practice as identified in other
studies to improve the safety [3, 4, 7, 12]. It has been
reported that establishing standardized morphine con-
centration infusions for paediatric N/PCA is complex,
as both bolus and continuous doses from the same
solution need to be delivered [14]. Considering this
challenge this study aimed to implement quality
assured standardized concentrations of paediatric N/
PCA morphine infusions, supplied as PFS, ready for
administration via pre-programmed safety pumps
(ALaris syringe Pumps) [15] to deliver accurate bolus
and continuous doses.
Methods
This project was conducted in two stages. The
pre-implementation which has previously been described
[11, 12]. This paper presents the findings of the imple-
mentation stage.
Design: mixed methods approach.
Intervention development
Establishing standard concentration
Using Excel all possible morphine concentrations from
1mg to 50mg in 50 mL for all possible weight ranges in
children from a lower weight limit of 1 kg upwards, were
proposed (ANR) and reviewed by a Consultant Paediat-
ric Pharmacist (ST). The criteria were:
 Total daily volume of morphine infusion should not
account for more than 15% of child’s total daily fluid
allowance.
 Daily treatment delivered using no more than three
syringes (ideally 1–2 syringes) per patient, to reduce
risks and workload from multiple syringe changes;
 Manufacture a limited number of standard
concentrations (safety and cost);
 Delivered by available infusion pumps for
continuous infusion rate and bolus dose, with a
minimum volume of 0.1 mL.
Proposed standard concentrations were reviewed and
approved by the Lead Paediatric Acute Pain Consultant
Anaesthetist (CD) and the Paediatric Clinical Nurse Spe-
cialist. Documentation, protocols, prescription labels
(used on medication charts), and reprogramming of in-
fusion pumps were approved (Paediatric Acute Pain
Team, Paediatric Consultant Pharmacist, hospital Clin-
ical Governance department).
The prefilled syringe containing morphine standard
concentration infusions are being prepared by the cen-
tralised intravenous admixture service (CIVAS), which is
a service run by the pharmacy department at our
hospital.
Risk assessment
Failure mode and effects analysis (FMEA) was used to
determine the risks/issues associated with changes to
the process of delivering paediatric N/PCA infusions
using morphine PFS containing standard concentration.
Before implementation a multidisciplinary team (17
members; nurses, doctors and pharmacists) familiar
with prescribing, preparing and administering mor-
phine N/PCA undertook a FMEA.
The FMEA team met twice over two months (Octo-
ber–November 2013). Before the FMEA, the research
team described the initial and final steps of the
process of delivering morphine infusion for N/PCA,
presented an overview of FMEA with a process
scheme example [16].
Team members described the steps undertaken when
prescribing, preparing, and administering morphine PFS
for N/PCA use, identified potential process failures and
determined severity, probability, and detectability scores
for these failures. They also made recommendations to
reduce the identified failures.
Education and training
Over three months (January–March 2014), in-house
training on the use of standardized concentrations for
paediatric N/PCA were provided (ANR, CD, ST) to all
nurses and doctors in theatres and wards. Standard op-
erating procedures (SOPs) for new documentation and
pump programming were produced. Posters of the
standard concentrations of morphine and SOPs were
placed in all clinical areas.
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Implementation
The implementation was conducted over eight months
(March – November 2014):
– Stage I: dummy run of whole system on one day
from theatre and transfer to a ward.
– Stage II: targeting one specific list of paediatric
orthopaedic operations with the same designated
consultant anaesthetist.
– Stage III: targeted lists extended to include spinal
cases and cleft cases, with an increased number of
anaesthetists and nursing staff participating.
– Stage IV: morphine PFS system was introduced
across all clinical areas.
The staged implementation was designed to identify
issues that arose when HCPs used the standardized mor-
phine PFS for N/PCA. It also supported training of
HCPs on the new system.
During implementation, all HCPs (doctors/nurses)
prescribing/preparing morphine PFS for paediatric N/
PCA, were observed (ANR). Data collected were patient
demographics (age, sex, weight); morphine prescription
details (PFS strength, N/PCA type); location; name of
nurse or doctor programming and prescribing; and time
spent prescribing, programming pump and administer-
ing a morphine PFS.
Sample size consideration for observation activity.
In 2011, 896 children were administered morphine for
N/PCA at the study hospital (internal report), with the
increase in surgery numbers, about 1000 children/year
would benefit directly from standardized morphine con-
centration infusions for N/PCA. With RTA a 100% re-
duction in preparation errors was assumed because of
the elimination of the individualized preparation stage
by HCPs. Based on the reported medication error per-
centage (1%) (internal medication error report), a sample
of 150 patients was required to provide a 95% confi-
dence interval for the true mean rate of 0.6 to 2.6%.
Evaluation of the intervention
Focus groups
All HCPs (doctors/nurses) who prescribing and prepar-
ing/administering morphine N/PCA in paediatric the-
atres or wards were invited to attend focus groups.
Signed informed consent was obtained from partici-
pants. Focus groups were conducted over 3–4 weeks
(March 2015) following implementation and evaluation
of the morphine PFS system post-implementation, to de-
termine HCPs views, concerns and any aspects to im-
prove the morphine PFS system.
Implementation across clinical areas
One week before the morphine PFS system’s hospital-wide
introduction date (1st April 2015), the new system was
publicized by email to staff and posters displayed in all
clinical areas. All previous protocols and paperwork were
removed and replaced with the new documentation.
Self-administered questionnaire
All HCPs (doctors/nurses) within paediatric theatres and
wards, who prepared/administered morphine N/PCA,
were surveyed 12 months after the morphine PFS system
implementation to determine staff views and satisfaction
with the morphine PFS system compared with the previ-
ous system (individually prepared syringes based on pa-
tient’s weight). The questionnaire was completed by
HCPs over 6 weeks (April–May 2016). New staff were
excluded because they had no experience of the previous
system.
A structured anonymous questionnaire was developed
based on previous studies [11, 12]. It included items
assessing satisfaction, attitudes and views of HCPs on
the recently implemented morphine PFS system together
with demographic data (location and job title). This
piloted questionnaire covered three themes: use; quality;
and impact of the morphine PFS system on patient
safety.
Hospital incident reports
Data of morphine N/PCA related incidents pre- and
post-implementation of morphine PFS system for Janu-
ary 2013–December 2015 were extracted from the hos-
pital electronic incident reporting system. Analysis of
reported incidents was conducted to identify any medi-
cation related incidents and to assess the impact of
implementing standard concentrations on reported error
occurrence.
Data analysis
Data was analysed using Stata 11 (StataCorp, College
Station, TX, USA). Descriptive statistics were performed
on data from observations, questionnaire, and medica-
tion incident reports, and presented as number, percent-
ages and mean ± standard deviation (SD), unless
otherwise specified. Chi-squared test was used for statis-
tical significant (p < 0.05) for categorical variables,
between wards and theatres.
Each focus group was transcribed verbatim and the
anonymized transcript uploaded to QSR NVivo (V.10)
software for coding and categorization to identify
themes. Qualitative content analysis was used with
five main themes being set a priori and supplemented
by emergent subthemes identified during analysis. An
iterative approach involving constant comparison was
employed where all data relating to each theme were
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constantly revisited after initial coding. Coding frames
were prepared and framework analysis created by
ANR and checked by ST independently.
Questionnaire data: the 5-point Likert questions were
grouped to three groups; “strongly agree” and “agree”
where considered as “agreement”, likewise “strongly
disagree” and “disagree” were considered “disagree-




Three standard concentrations were established for
paediatric N/PCA use (Table 1). Protocols and prescrip-
tion labels were also developed (Additional file 1: Figure
S1-S4).
Risk assessment
Seventeen (89.5%, 17/19) HCPs participated in the
FMEA meetings (Additional file 1: Table S1). FMEA
identified potential failures which might occur when
using morphine PFS system for N/PCA as well as rec-
ommendations to address these aspects (Table 2).
The two aspects with the highest potential for fail-
ure were identified at ward level due to limited stor-
age space and staff selection of the wrong strength.
The risk assessment resulted in a staged implementa-
tion (I-IV).
Observation of HCP setting up N/PCA using morphine PFS
A total of 175 morphine PFS (theatres 157, wards 18)
were administered to 157 children [mean (sd); age
9.4 years ±5.1, mean weight 32.4 kg ± 15.2, weight
range 5–54 kg] were observed. Fig. 1 shows the pre-
and post-implementation processes of setting up mor-
phine PFS paediatric N/PCA. Using morphine PFS,
resulted in fewer steps in the preparation process (5
compared to 9 steps). When programming the infu-
sion pump, the infusion concentration was pre-set
and fixed which reduced the values needed to be
programmed (4 to 3 steps). Therefore, less time was
required to set up each PFS.
Overall the total mean time required to set up N/
PCA for a child (prescribing, programming pump/
administering) was 3.7 ± 1.7 (sd) minutes. There was a
significant difference between theatres and wards
(theatre 3.6 ± 1.7; ward 4.7 ± 1.3 min, p < 0.01). This
suggested that theatre staff might be faster in setting
up a N/PCA for various reason; e.g. could be because
of the theatre and ward’s layout, i.e. theatre have the
drug, paperwork and the patient in one place. While
on the ward, nurses have to be between drug room
and patient bedside.
The overall time spent by HCPs using the previous
system to set up N/PCA for a child has been re-
ported [11]. There was a significant difference be-
tween the morphine PFS system and previous system
(3.7 ± 1.7 vs. 11.9 ± 4.1, P < 0.001 and between the-
atres (morphine PFS system 3.6 ± 1.7; previous system
10.5 ± 3.3, p < 0.001) and wards (morphine PFS sys-
tem 4.7 ± 1.3; previous system14.5 ± 4.0, p < 0.001).
The majority of prescriptions were for NCA use
(116/175, 66.3%), of which 69% (80/116) were for strength
50mg/50mL and 31% (36/116) for 10mg/50mL. Only 59
prescriptions were for PCA using 50mg/50mL PFS.
Evaluation of the intervention
Focus groups
Two focus groups were conducted with participants re-
cruited from three different clinical areas; focus group 1
ward and recovery nurses (n = 7); focus group 2 paediat-
ric anaesthetists (n = 5) from theatres.
Five main themes were identified: 1) the process of
using morphine PFS system to set up N/PCA infusion;
2) impact of this system on the process of preparing/ad-
ministering morphine N/PCA; 3) concerns about this
system; 4) suggestions to address concerns with this sys-
tem; 5) impact of this system on practice and patient
care. Table 3 summarizes theme and subthemes
identified.
All focus group participants preferred using the mor-
phine PFS system and had positive comments. The mor-
phine PFS system was described as easier and safer;
because it eliminated errors with calculations, dose re-
ceived by the patient, reduced infection risk and less
time consuming. Example quotes from focus group
participants;
One of the participated nurses commented that “It
[morphine PFS system] is much easier than starting that
from the scratch … time is less than [it] used to be.”
While one of the anaesthetists said that morphine PFS
system is “Unquestionably quicker”.
The risk of selecting the wrong strength of morphine
PFS was the main concern raised by participants. How-
ever, it was identified that it could be mitigated by en-
forcing the hospital policy of double-checking IV
infusions by two people. Other measures suggested
Table 1 Weight bands and morphine standardized prefilled
syringe strengths established for N/PCAª
Weight band Protocol Morphine PFS strength
Weight≤ 3.9 kg NCA 3mg in 50 mL Glucose 5%
Weight≥ 4 kg – 19.9 kg NCA 10 mg in 50mL Sodium
Chloride 0.9%
Weight≥ 20 kg NCA 50mg in 50mL Sodium
Chloride 0.9%
Weight≥ 25 kg PCA
aN/PCA: Nurse- or/ Patient-Controlled Analgesia
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were bar-coding and using electronic storage cabinets
(Table 3).
Self-administered questionnaire
A total of 125 questionnaires (62.0%, 125/200) were
completed (ward = 100, theatre = 25). Most respondents
(90.4%, 113/125) were satisfied using the morphine PFS
system and 8.8% (11/125) were neutral. Only one
respondent (0.8%), who provided no explanation, was
dissatisfied (Table 4).
Overall, most respondents (95.2%, 119/125) believed
that using the PFS improved patient safety and 89.6%
(112/125) indicated that the morphine PFS system mini-
mized preparation/administration errors.
Majority of respondents (90.4%, 113/125: ward = 93,
theatre = 20) reported that morphine PFS system
decreased drug delivery time because set up time for an
N/PCA infusion was quicker compared to the previous
system; with 53.1% (60/113; ward = 51, Theatre = 9)
reporting it took less than 5min to set up a PFS. Most
respondents (91.2%, 114/125) suggested that pre-pro-
gramming of the infusion pumps was better compared to
the previous system. Only one individual (ward nurse), re-
ported the new system was much slower (> 25min), how-
ever no explanation was provided. Four respondents from
theatre did not answer this question as they had not set
up a smart pump with a prefilled syringe.
Hospital incident reports
A total of 198 incident reports related to morphine re-
ported pre-and post-implementation, were analysed, of
which 54 (27.3%, 54/198) were related to N/PCA. Fig. 2
describes the reports (63%, 34/54) linked to the previous
system (i.e. preparing individual syringe based on patient
weight) and the reports (37%, 20/54) with the morphine
PFS system.
Overall there was a 41.2% decrease in the occurrence
of reported medication incidents following implementa-
tion of the standard concentrations for N/PCA use. Al-
though this reduction was not statistically significant (p
= 0.115), it is considered important, because incidents
such as “wrong dose of medication administered to pa-
tient” and “dose or strength selected was wrong or un-
clear” were not reported in the morphine PFS system.
They had been reported for the previous system [23.5%
(8/34); 2.9% (1/34), respectively].
The incidence of “expiry date’s wrong, omitted or
passed” (25%, 5/20) was higher in the morphine PFS sys-
tem compared to the previous system (5.9%, 2/34).
The majority of reported incidents were reported to
have “no harm” (51/54). Only three were reported as
“low harm”, all related to the previous system (Fig. 2).
Discussion
The main finding of this study is that the established
standardized concentrations of morphine provided in
Fig. 1 Process of prescribing, preparing and administering morphine N/PCA pre- and post-implementation of PFS containing morphine
standardised concentrations at the participated hospital. CD: controlled drug, IV: intravenous; PFS: prefilled syringe. Highlighted steps in blue in
the preparation stage were eliminated after introducing PFS system. Green boxes show the changes in those steps pre- and post-implementation
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PFS were implemented successfully across all clinical
areas in our hospital to deliver N/PCA infusion; both
bolus and continuous doses from the same syringe, in
children. While standard concentrations of some
intravenous (IV) drugs have been widely used for IV
infusions in various healthcare systems [4–7], this was
the first study within a paediatric hospital where stan-
dardized morphine concentrations in “ready-to-admin-
ister (RTA)” infusions were implemented to deliver
paediatric N/PCA infusions.
The data derived and feedback collected provided an
evidence base that encouraged HCPs’ acceptance of the
change to standardized concentration infusions for paedi-
atric N/PCA.
The new system eliminated the need to calculate the
concentration and reducing the risk of microbial
Table 3 Summary of topic themes and subthemes identified
from the focus groups
Theme Subthemes




Prescribing - paper work




Changing syringes on ward
Impact of the morphine PFS
system on the process of
preparing/administering
morphine N/PCA
Faster – less time consuming
Easier to set up
No calculation of concentration
Safer – less errors
Eliminating any errors of how
much patient is getting
Less infection risks
Paperwork and pump programming
much easier to read
Fixed standardized concentrations in
all clinical areas
Use same dose as previous system
but volume vary for each patient
Volume of continuous and bolus
doses cannot be used as safety net
as previous system
Concerns about the morphine
PFS system
Risk of picking up the wrong PFS
Out of stock - due to storage limit
space or expiry
Human error still same as previous
system
Suggestions to overcome
concerns and improve the
morphine PFS system
Emphasize on the double checking
as safety mechanism
Possibility of introducing standard
concentration in 50-ml vials to
extend expiry and maximize stock
storage
Possibility of storing PFS in Omnicell
to increase stock level
Make up standard concentration in
case of out-of-stock PFS
Order before it ran-out or expired
Look into using of barcoding syringe,
label and prescription to avoid wrong
selection of syringe
Impact of the morphine




Less risk of errors - improve patient
safety
Allow focus on the patient rather
than on paperwork and preparation
Give more time for teaching trainee
N/PCA: Nurse- or/ Patient-Controlled Analgesia; PFS: pre-filled syringe;
Omnicell: electronic storage cabinet
Table 4 Summary of the questionnaire results




Evaluation of the morphine PFS system for N/PCA; n (%)
Set up time is quicker (5–9 min) 1 (0.8) 11 (8.8) 113 (90.4)
New paperwork easier to use 2 (1.6) 26 (20.8) 97 (77.6)
If PFS out-of-stock; easier to
prepare standard concentration
than previous system (prepare
individual syringe based on
patient weight)
6 (4.8) 42 (33.6) 77 (61.6)
Little impact of distraction
when setting up PFS
compared to previous
system
27 (21.6) 36 (28.8) 62 (49.6)
Satisfied with using morphine
PFS on daily practice
1 (0.8) 11 (8.8) 113 (90.4)
Quality of the morphine PFS system
Less time spend in setting up
PFS is beneficial
0 5 (4.0) 120 (96)
Using PFS avoid waste of
morphine ampoules
2 (1.6) 15 (12.0) 105 (84)




0 16 (12.8) 109 (87.2)
the morphine PFS system
helped in making the process
of administering N/PCA
infusion safer
4 (3.2) 10 (8.0) 111 (88.8)
The morphine PFS system
help to provide better
quality of care to paediatric
patients
2 (1.6) 35 (28.0) 88 (70.4)
Using PFS help in reducing
incidents of injury might
result from breaking
ampoules
1 (0.8) 27 (21.6) 97 (77.6)
The morphine PFS system
provide more accurate dosing
4 (3.2) 35 (28.0) 86 (68.8)
Impact of the morphine PFS system
on patient safety
Overall the morphine PFS
system help to improve
patient safety
0 6 (4.8) 119 (95.2)
Percentages (%) calculated out of the total number of respondents (n = 125)
N/PCA: Nurse- or/ Patient-Controlled Analgesia; PFS: pre-filled syringe
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contamination providing a safer and more time efficient
system. This was evidenced by observation, findings from
focus groups and survey questionnaire. Furthermore, the
pre-implementation study [11] identified that 61.5% of
individually prepared syringes deviated unacceptably
from the intended morphine concentration. Infusions
prepared on an individual patient basis in clinical
areas are prone to such errors, which are classically
‘unseen errors’ because syringe content is not rou-
tinely analysed and therefore not captured by incident
reporting systems. Such errors are eliminated in the
new system through batch manufactured, quality
assured morphine PFS.
The main goal in implementing morphine PFS
containing standard concentrations was to improve
paediatric patient safety by minimizing the risk of
medication errors. Twelve months following imple-
mentation, there was a reduction in medication errors
compared with the pre-implementation period. Al-
though this was not statistically significant, from clin-
ical perspective it was considered important because
the newly implemented system eliminated errors asso-
ciated with infusion preparation. Medication errors
associated with intravenous infusion have previously
been reduced using standard concentrations [4]. Im-
portantly, the new system did not increase other types
of medication error e.g. delivery of the wrong dose.
The follow-up survey demonstrated that staff
perceived that the morphine PFS improved medica-
tion safety and resulted in reduced set up time.
Limitations
The study has some limitations that need to be con-
sidered when interpreting our results. Observations of
HCPs prescribing/preparing morphine PFS for N/PCA
were conducted during day shifts (8 am - 5 pm) Mon-
day to Friday. Therefore, any use of the morphine
PFS system during other times was not undertaken.
Whilst errors are generally under–reported [17],
highlighting a process (positively or negatively) tends
to lead to increased reporting [18]. Bias in reporting
errors linked to the morphine PFS system might have
occurred as it was well publicized. The incidents
report data captured post-implementation might be
relatively low due to the short period it was
conducted within, therefore, it is recommended to re-
analyse incidents reports over a longer period
post-implementation.
The use of the lowest strength morphine PFS (3 mg/
50mL) was not observed. Finally, not all staff who par-
ticipated in the implementation of the morphine PFS
system attended focus groups; however, a follow-up
self-administered survey, 12 months after implementa-
tion, was conducted to capture the impact of this system
on HCPs practice and satisfaction.
Fig. 2 Number of morphine N/PCA related errors reported pre- and post-implementation of morphine PFS system. Low harm incidents related to
previous system; “adverse reaction when drug used as intended”; “wrong dose (concentration) of drug administered”; “medicine omitted” (i.e. PCA
infusion discontinued without conversion to oral dose of opioid leaving the patient in pain)
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Conclusions
The implementation of standardized concentration of
morphine infusions for N/PCA was achieved in all clin-
ical areas in our hospital and satisfied the requirements
for delivering continuous infusions and bolus doses for
children weighing 1–50 kg. This led to improved patient
safety in the study hospital, by reducing medication
errors reported post implementation of morphine PFS
system. This system supported HCPs to more safely de-
liver a high-risk medicine to children, resulting in a
quality improvement within the healthcare system in our
hospital.
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Additional file 1: Figure S1-S4 Morphine standard concentrations: N/
PCA colour-coded protocols and medication charts’ prescription labels.
Table S1 Demographic details of the 17 HCPs who took part in the
FMEA. (DOCX 3753 kb)
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